Skip to main content

Visium Asset Management, LP

13F filer · CIK 0001377452
Last filed Aug 12, 2016
Inactive · not filing 13F
13F portfolio value$0U.S. long equity reported on 13F
Positions251103 new · 227 closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight11.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2016Reported Aug 12, 2016251 positions
MPCMarathon Petroleum Corp$25.6M1.79%0.13%Not reportedQ3 2013
YHOOAltaba Inc.$22.5M1.58%0.06%-54.1%Q2 2013
KBRKBR, Inc.$22.5M1.58%1.19%Not reportedQ4 2013
QTNTQuotient Limited$18.4M1.29%9.33%-4.2%Q2 2014
CSODCornerstone OnDemand Inc$15.1M1.06%0.71%-28.7%Q4 2014
CTBCooper Tire & Rubber Co$15M1.05%0.91%+57.1%Q2 2013
WREvergy Kansas Central, Inc.$13.4M0.94%0.17%+56.9%Q4 2013
VVisa Inc.$12.3M0.86%0.01%-57.1%Q2 2013
NDAQNasdaq, Inc.$10.4M0.72%0.10%+220.1%Q4 2014
METAMeta Platforms, Inc.$10.2M0.71%Not reported+3.9%Q3 2013
ICEIntercontinental Exchange, Inc.$9.88M0.69%0.03%+242.6%Q4 2013
ETFCE Trade Financial Corp$9.29M0.65%0.14%+45.2%Q2 2013
STJST Jude Medical, LLC$9.27M0.65%0.04%-65.9%Q2 2013
EMCEmc Corp$9.19M0.64%0.02%-59.7%Q2 2013
PTCPTC Inc.$8.99M0.63%0.21%+11.4%Q1 2016
AUAngloGold Ashanti PLC$8.88M0.62%Not reported-43.6%Q1 2015
HDHome Depot, Inc.$8.86M0.62%0.01%-72.6%Q2 2013
HUMHumana Inc$8.72M0.61%0.03%-83.9%Q3 2013
AVGOBroadcom Inc.$8.63M0.60%0.01%+107.7%Q4 2015
MTGMgic Investment Corp$8.46M0.59%0.42%Not reportedQ2 2013
WRBBerkley W R Corp$8.35M0.58%0.11%-57.9%Q2 2014
SRAQUPermian Resources Corp$8.21M0.57%Not reportedNot reportedQ1 2016
HPPHudson Pacific Properties, Inc.$8.15M0.57%0.28%NewQ2 2016
MTSIMACOM Technology Solutions Holdings, Inc.$8.05M0.56%0.46%+2.5%Q4 2015
DVNDevon Energy Corp$7.82M0.55%0.04%-4.0%Q2 2013
CBChubb Ltd$7.77M0.54%0.01%-40.7%Q2 2013
AIZAssurant, Inc.$7.43M0.52%0.14%-57.5%Q1 2014
SCGScana Corp$7.41M0.52%0.07%+219.4%Q3 2013
STNGScorpio Tankers Inc.$7.41M0.52%Not reportedNewQ2 2016
ALJAlon USA Energy, Inc.$7.19M0.50%1.56%+2.5%Q4 2013
MAMastercard Inc$6.99M0.49%0.01%Not reportedQ3 2013
AJRDAerojet Rocketdyne Holdings, Inc.$6.9M0.48%Not reported-4.1%Q4 2015
PVTBPrivatebancorp, Inc$6.84M0.48%0.20%NewQ2 2016
WDCWestern Digital Corp$6.73M0.47%0.06%Not reportedQ4 2013
UVEUniversal Insurance Holdings, Inc.$6.72M0.47%1.03%-54.8%Q1 2015
LSXMALiberty Media Corp$6.4M0.45%Not reportedNewQ2 2016
CLRContinental Resources, Inc$6.29M0.44%0.04%-84.1%Q2 2014
PRAProassurance Corp$6.28M0.44%0.22%-37.0%Q2 2014
GRFSGrifols SA$6.25M0.44%Not reported-43.3%Q2 2013
VRValidus Holdings Ltd$6.24M0.44%0.16%-70.1%Q3 2013
CRMSalesforce, Inc.$6.2M0.43%0.01%-79.0%Q2 2014
METMetlife Inc$6.2M0.43%0.01%-77.8%Q3 2013
EXCExelon Corp$5.98M0.42%0.02%Not reportedQ2 2013
EGOEldorado Gold Corp$5.85M0.41%Not reportedNot reportedQ2 2013
VOYAVoya Financial, Inc.$5.84M0.41%0.12%-64.6%Q4 2014
SNPSSynopsys Inc$5.36M0.37%0.07%-41.9%Q1 2014
ACGLArch Capital Group Ltd.$5.26M0.37%0.06%-36.2%Q1 2014
CICigna Group$5.17M0.36%Not reported-92.2%Q3 2013
AMEAmetek Inc/$5.13M0.36%0.05%-32.2%Q2 2013
LRCXLam Research Corp$5.1M0.36%0.04%+49.2%Q2 2013
Q1 2016Reported May 16, 2016374 positions
AGNAllergan Inc$264M4.49%0.32%-10.1%Q2 2013
ENDPEndo Health Solutions Inc.$188M3.20%5.78%+29.2%Q2 2013
PCRXPacira BioSciences, Inc.$119M2.02%6.03%-2.3%Q2 2013
CNCCentene Corp$104M1.76%0.99%Not reportedQ4 2014
BIIBBiogen Inc.$99.3M1.69%0.17%Not reportedQ2 2013
ZLTQZeltiq Aesthetics Inc$78M1.33%7.29%+17.3%Q4 2013
NBIXNeurocrine Biosciences Inc$73.7M1.25%2.15%-15.3%Q2 2013
CICigna Group$71.2M1.21%Not reported+109.5%Q3 2013
HTAHealthcare Realty Trust Inc$70.1M1.19%Not reported-22.6%Q2 2013
GILDGilead Sciences, Inc.$69.1M1.18%0.06%+21319.8%Q2 2013
CNMDCONMED Corp$64.5M1.10%5.55%-14.9%Q2 2014
PFEPfizer Inc$63.6M1.08%0.03%+29.3%Q2 2013
ALGNAlign Technology Inc$58.4M0.99%1.00%+5.6%Q2 2013
MCKMckesson Corp$58.4M0.99%0.16%+88.9%Q2 2013
CBPOChina Biologic Products Holdings, Inc.$55.5M0.94%Not reported+14.7%Q2 2013
HUMHumana Inc$55.1M0.94%0.20%+400.3%Q3 2013
SPNCSpectranetics Corp$52.2M0.89%8.40%+54.3%Q3 2013
ZBHZimmer Biomet Holdings, Inc.$51.9M0.88%0.24%-44.4%Q2 2013
FGENKyntra Bio, Inc.$50.3M0.86%Not reported+16.3%Q4 2014
SAGESage Therapeutics, Inc.$50M0.85%4.87%+45.1%Q1 2015
ALNYAlnylam Pharmaceuticals, Inc.$49.7M0.85%0.93%+681.8%Q1 2015
AXGTSio Gene Therapies Inc.$48.1M0.82%5.59%-17.4%Q2 2015
YHOOAltaba Inc.$48.1M0.82%0.14%-9.0%Q2 2013
HZNPHorizon Therapeutics Public Ltd Co$46.5M0.79%1.75%-5.3%Q1 2014
AIGAmerican International Group, Inc.$40.8M0.69%0.07%+6.6%Q2 2013
MEDMedifast Inc$40.8M0.69%11.41%Not reportedQ2 2013
BKDBrookdale Senior Living Inc.$38.1M0.65%1.26%-60.0%Q3 2013
PRTAProthena Corp Public Ltd Co$36.7M0.62%2.60%-8.9%Q1 2015
DHRDanaher Corp$36.3M0.62%0.06%+90.8%Q2 2013
UHSUniversal Health Services Inc$35.5M0.60%Not reported+542.8%Q2 2013
BHIBaker Hughes Holdings LLC$33.9M0.58%0.18%+10.1%Q2 2013
RAREUltragenyx Pharmaceutical Inc.$33.9M0.58%1.37%-15.1%Q1 2014
HDHome Depot, Inc.$33.8M0.57%0.02%+221.3%Q2 2013
PRGOPERRIGO Co plc$33.7M0.57%0.18%-63.1%Q2 2013
HESHess Corp$32.4M0.55%Not reportedNot reportedQ2 2013
METMetlife Inc$30.8M0.52%0.06%+100.0%Q3 2013
AMRIAlbany Molecular Research Inc$30.7M0.52%5.61%-4.3%Q3 2013
VVisa Inc.$29.5M0.50%0.02%+18.6%Q2 2013
ICLRIcon PLC$29M0.49%0.70%Not reportedQ2 2013
ZTSZoetis Inc.$29M0.49%0.13%+58.1%Q2 2013
BAXBaxter International Inc$28.3M0.48%0.13%-33.4%Q2 2013
CRMSalesforce, Inc.$27.4M0.47%0.06%+24.2%Q2 2014
CLRContinental Resources, Inc$26.5M0.45%0.23%+51.4%Q2 2014
ASNDAscendis Pharma A/S$26.1M0.44%Not reported+2.7%Q1 2015
CNQCANADIAN NATURAL RESOURCES Ltd$25.4M0.43%Not reportedNot reportedQ4 2013
LJPCLa Jolla Pharmaceutical Co$24.8M0.42%6.50%+88.4%Q3 2014
AMPAmeriprise Financial Inc$24.7M0.42%0.16%Not reportedQ2 2014
ITCIIntra-Cellular Therapies, Inc.$24.5M0.42%2.04%-12.3%Q1 2014
XLXL Group Ltd$24M0.41%0.23%+33.1%Q4 2013
HONHoneywell International Inc$23.2M0.40%0.03%-6.7%Q2 2013
Q4 2015Reported Feb 12, 2016419 positions
AGNAllergan Inc$342M5.14%0.36%+9.9%Q2 2013
ENDPEndo Health Solutions Inc.$317M4.76%4.47%-0.6%Q2 2013
PCRXPacira BioSciences, Inc.$176M2.64%6.22%-22.4%Q2 2013
NBIXNeurocrine Biosciences Inc$125M1.87%2.55%+0.1%Q2 2013
BKDBrookdale Senior Living Inc.$111M1.66%3.18%+278.4%Q3 2013
PRGOPERRIGO Co plc$103M1.55%0.50%-60.4%Q2 2013
AXGTSio Gene Therapies Inc.$91.5M1.38%5.12%-1.6%Q2 2015
ZBHZimmer Biomet Holdings, Inc.$89.8M1.35%0.43%+7.5%Q2 2013
HTAHealthcare Realty Trust Inc$83M1.25%Not reported-3.1%Q2 2013
CNMDCONMED Corp$79.6M1.20%6.52%-22.7%Q2 2014
RAREUltragenyx Pharmaceutical Inc.$70.7M1.06%1.62%-0.2%Q1 2014
ZLTQZeltiq Aesthetics Inc$69.9M1.05%6.24%+95.2%Q4 2013
PRTAProthena Corp Public Ltd Co$66.7M1.00%3.08%+2.0%Q1 2015
HZNPHorizon Therapeutics Public Ltd Co$64.2M0.96%1.85%+65.5%Q1 2014
SAGESage Therapeutics, Inc.$62.7M0.94%3.73%+19.1%Q1 2015
FGENKyntra Bio, Inc.$61.9M0.93%Not reported+1.0%Q4 2014
CBPOChina Biologic Products Holdings, Inc.$60.2M0.90%Not reported-18.2%Q2 2013
ITCIIntra-Cellular Therapies, Inc.$54M0.81%2.32%+1.3%Q1 2014
PFEPfizer Inc$53.6M0.80%0.03%+68.0%Q2 2013
ALGNAlign Technology Inc$50.1M0.75%0.96%-44.4%Q2 2013
YHOOAltaba Inc.$47.7M0.72%0.15%+36.7%Q2 2013
MHKMohawk Industries Inc$47.4M0.71%0.34%+5.7%Q3 2013
NEENextera Energy Inc$45.4M0.68%0.09%+107.0%Q2 2013
AIGAmerican International Group, Inc.$43.8M0.66%0.06%+76.3%Q2 2013
ELVElevance Health, Inc.$43.4M0.65%0.12%Not reportedQ4 2014
AMRIAlbany Molecular Research Inc$41.7M0.63%5.10%-36.4%Q3 2013
MEDMedifast Inc$41M0.62%11.44%Not reportedQ2 2013
BAXBaxter International Inc$39.4M0.59%0.19%+5806.7%Q2 2013
MCKMckesson Corp$38.8M0.58%0.09%-69.2%Q2 2013
PCPPrecision Castparts Corp$36.3M0.55%0.11%+2.8%Q3 2013
CICigna Group$36.2M0.54%Not reported-76.1%Q3 2013
HIGHartford Insurance Group, Inc.$35.3M0.53%0.20%+232.5%Q2 2013
SPNCSpectranetics Corp$35.1M0.53%5.46%+19.4%Q3 2013
QTNTQuotient Limited$32.5M0.49%9.68%+21.3%Q2 2014
BHIBaker Hughes Holdings LLC$32.4M0.49%0.16%+7.3%Q2 2013
EWEdwards Lifesciences Corp$31.1M0.47%0.18%-16.5%Q3 2013
ACADAcadia Pharmaceuticals Inc$30.9M0.46%0.85%+0.7%Q2 2013
TEVATeva Pharmaceutical Industries Ltd$30.8M0.46%0.05%Not reportedQ3 2013
AAgilent Technologies, Inc.$29.7M0.45%0.21%+245.1%Q2 2013
SLBSLB Limited$27.2M0.41%0.03%-25.5%Q2 2013
BPMCBlueprint Medicines Corporation$26.9M0.40%3.77%Not reportedQ2 2015
BSXBoston Scientific Corp$25.9M0.39%0.10%+12327.4%Q4 2013
SYFSynchrony Financial$25.7M0.39%0.10%+5371.6%Q1 2015
NVRONevro Corp.$25.5M0.38%1.34%+67.6%Q4 2014
ACEChubb Ltd$25.5M0.38%Not reported-39.1%Q2 2013
CMECme Group Inc.$25.4M0.38%0.08%+99.0%Q3 2013
VVisa Inc.$25.2M0.38%0.02%-8.4%Q2 2013
ASNDAscendis Pharma A/S$25.1M0.38%Not reportedNot reportedQ1 2015
UVEUniversal Insurance Holdings, Inc.$24M0.36%2.95%+1349.2%Q1 2015
AKRXQAkorn Inc$23.6M0.35%Not reported+917.3%Q1 2015
Q3 2015Reported Nov 16, 2015691 positions
ENDPEndo Health Solutions Inc.$361M4.92%4.50%+40.2%Q2 2013
PRGOPERRIGO Co plc$284M3.88%1.23%-13.7%Q2 2013
AGNAllergan Inc$271M3.70%0.32%+43445.9%Q2 2013
VRXValeant Pharmaceuticals International$184M2.51%1.36%+24.1%Q2 2013
CICigna Group$140M1.91%Not reportedNot reportedQ3 2013
PCRXPacira BioSciences, Inc.$121M1.66%8.03%+380.1%Q2 2013
MCKMckesson Corp$118M1.61%0.28%+133.4%Q2 2013
CNMDCONMED Corp$112M1.53%8.44%-0.1%Q2 2014
AETAetna Inc$103M1.40%0.27%-23.6%Q2 2013
MNTAMomenta Pharmaceuticals Inc$88.6M1.21%7.84%+30.4%Q2 2013
NBIXNeurocrine Biosciences Inc$87.5M1.20%2.56%+9.6%Q2 2013
THCTenet Healthcare Corp$85.2M1.16%2.32%+492.4%Q2 2013
HTAHealthcare Realty Trust Inc$77.9M1.06%Not reported+10.2%Q2 2013
ALGNAlign Technology Inc$77.7M1.06%1.72%+35.3%Q2 2013
ZBHZimmer Biomet Holdings, Inc.$76.5M1.04%0.40%-18.8%Q2 2013
CLVSClovis Oncology, Inc.$71.9M0.98%2.04%+4.1%Q2 2013
AXGTSio Gene Therapies Inc.$66.7M0.91%5.20%+1.6%Q2 2015
BIIBBiogen Inc.$65M0.89%0.09%+8121.5%Q2 2013
RAREUltragenyx Pharmaceutical Inc.$60.8M0.83%1.63%-5.6%Q1 2014
AMRIAlbany Molecular Research Inc$57.5M0.79%9.31%+3.1%Q3 2013
ZTSZoetis Inc.$48.1M0.66%0.23%+27.1%Q2 2013
CBPOChina Biologic Products Holdings, Inc.$46.4M0.63%Not reported+3.2%Q2 2013
FGENKyntra Bio, Inc.$44.1M0.60%Not reported+28.1%Q4 2014
XLXL Group Ltd$44M0.60%0.40%+3.2%Q4 2013
PRTAProthena Corp Public Ltd Co$43.5M0.59%3.04%-3.8%Q1 2015
MHKMohawk Industries Inc$43M0.59%0.32%+352.7%Q3 2013
ZLTQZeltiq Aesthetics Inc$40.2M0.55%3.22%+218.9%Q4 2013
ITCIIntra-Cellular Therapies, Inc.$39.7M0.54%2.30%-5.8%Q1 2014
WWayfair Inc.$39.6M0.54%Not reported+994.6%Q1 2015
SAGESage Therapeutics, Inc.$38.2M0.52%3.14%+37.5%Q1 2015
ACEChubb Ltd$37.1M0.51%Not reported+33.3%Q2 2013
BKDBrookdale Senior Living Inc.$36.4M0.50%0.84%-36.1%Q3 2013
MEDMedifast Inc$36.3M0.50%11.48%Not reportedQ2 2013
SLBSLB Limited$36.1M0.49%0.04%+11418.2%Q2 2013
HZNPHorizon Therapeutics Public Ltd Co$35.5M0.48%1.12%+6.3%Q1 2014
PPLPPL Corp$35.4M0.48%0.16%+25.6%Q2 2013
PCPPrecision Castparts Corp$35M0.48%0.11%+8916.8%Q3 2013
GPKGraphic Packaging Holding Co$34.9M0.48%0.83%+142.4%Q4 2013
BHIBaker Hughes Holdings LLC$34.1M0.47%0.15%+31.1%Q2 2013
ALRInverness Medical Innovations Inc$33.9M0.46%0.82%+36.6%Q4 2013
EWEdwards Lifesciences Corp$33.5M0.46%0.22%-39.3%Q3 2013
PFEPfizer Inc$31M0.42%0.02%+335.0%Q2 2013
YHOOAltaba Inc.$30.3M0.41%0.11%+20.4%Q2 2013
KNDKindred Healthcare, Inc$29.2M0.40%2.21%-4.8%Q4 2014
CRMSalesforce, Inc.$28.7M0.39%0.06%+19.3%Q2 2014
VCVisteon Corp$28.6M0.39%0.69%+10.7%Q2 2013
ACADAcadia Pharmaceuticals Inc$28.5M0.39%0.85%+3.0%Q2 2013
ATRAAtara Biotherapeutics, Inc.$26.2M0.36%2.94%-8.0%Q4 2014
VVisa Inc.$24.7M0.34%0.02%+55.3%Q2 2013
ASNDAscendis Pharma A/S$24.2M0.33%Not reported+437.3%Q1 2015
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.